A Phase III study for evaluation of immunogenicity and reactogenicity of Fluarix™ (Influspit SSW®) 2006/2007 in people aged 18 years or above

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-001918-33

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the humoral response (anti-haemagglutinin antibody tested by haemagglutination inhibition) against each vaccine strain in adults aged 18 years or above 21 days after vaccination with Fluarix™/Influspit SSW® 2006/2007.


Critère d'inclusion

  • Immunization against influenza of healthy adults

Liens